跳至主要内容
临床试验/NCT02905955
NCT02905955Unknown4 期

Negative Pressure Wound Management (NPWT) System for Inguinal Wounds After Venous Hybrid Procedures

Maastricht University Medical Center2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2016年9月最近更新:
适应症

试验速览

阶段
4 期
入组人数
40
试验地点
2
主要终点
Number of Patients With wound infections or Adverse Events That Are Related to Prevena incision management negative pressure wound therapy

研究概览

简要总结

All patients with deep venous obstruction below the sapheno-femoral junction elective for hybrid procedure with creation of an arterio venous-fistula (AVF) in the MUMC or patients with primary percutaneous procedure (and thus venous obstruction above the sapheno-femoral junction) who present with occluded stents which need an additional AVF after thrombolysis will receive a Prevena NPWT. Incidence of wound infections and wound scoring will be performed afterwards.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • All patients with deep venous obstruction below the sapheno-femoral junction primary elective for hybrid procedure with creation of an AV-fistula in the MUMC
  • Be able to communicate in Dutch
  • Life expectancy >1 year

排除标准

  • Patients with allergies for the components of the used negative pressure incision management system (Prevena)

结局指标

主要结局

Number of Patients With wound infections or Adverse Events That Are Related to Prevena incision management negative pressure wound therapy

时间窗: 3 months

Patients will be prospectively followed and checked for development of wound infections (grade 1-5). Therapy to treat the infections will be monitored.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验